AUSTIN, TX / ACCESSWIRE / November 23, 2020 / Apollo Endosurgery, Inc. ('Apollo') (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in the 32nd Annual Piper Sandler Healthcare Conference.

December 1-2, 2020

32nd Annual Piper Sandler Healthcare Conference

Apollo management will participate in virtual one on one meetings. A fireside chat overview presentation has been pre-recorded and will be available to Piper Sandler clients.

Investors interested in attending the virtual presentation or arranging meetings should contact their respective Piper Sandler representative or Apollo's investor relations, Matt Kreps of Darrow Associates, mkreps@darrowir.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on the Nasdaq Global Market under the symbol 'APEN'. For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contacts:

Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com

SOURCE: Apollo Endosurgery, Inc.